xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.23262, Wiley Online Library on [02/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

432

KUANetal.

ence at a single institution. J Neurol Surg B Skull Base . 2023;84(1):51-59. https://doi.org/10.1055/s-0041-1740968 1475. Moya-Plana A, Aupérin A, Obongo R, et al. Oncologic out comes, prognostic factor analysis and therapeutic algorithm evaluation of head and neck mucosal melanomas in France. Eur J Cancer . 2019;123:1-10. https://doi.org/10.1016/j.ejca.2019. 09.007 1476. Chłopek M, Lasota J, Thompson LDR, et al. Alterations in key signaling pathways in sinonasal tract melanoma. A molecular genetics and immunohistochemical study of 90 cases and comprehensive review of the literature. Mod Pathol . 2022;35(11):1609-1617. https://doi.org/10.1038/s41379 022-01122-7 1477. Gal TJ, Silver N, Huang B. Demographics and treat ment trends in sinonasal mucosal melanoma. Laryngoscope . 2011;121(9):2026-2033. https://doi.org/10.1002/lary.21925 1478. Jangard M, Hansson J, Ragnarsson-Olding B. Primary sinonasal malignant melanoma: a nationwide study of the Swedish population, 1960-2000. Rhinology . 2013;51(1):22-30. https://doi.org/10.4193/Rhino12.075 1479. Rose AAN, Armstrong SM, Hogg D, et al. Biologic subtypes of melanoma predict survival benefit of combination anti PD1 + anti-CTLA4 immune checkpoint inhibitors versus anti PD1 monotherapy. J Immunother Cancer . 2021;9(1):e001642. https://doi.org/10.1136/jitc-2020-001642 1480. Rossi E, Schinzari G, Maiorano BA, et al. Efficacy of immune checkpoint inhibitors in different types of melanoma. Hum Vaccin Immunother . 2021;17(1):4-13. https://doi.org/10.1080/ 21645515.2020.1771986 1481. Guo R, Jenkins SM, Johnson BJ, Reed K, Kroneman T, Choby G. Sinonasal mucosal melanoma: role of tumor proliferative indices and pathological factors in survival. Laryngoscope . 2022;132(12):2350-2358. https://doi.org/10.1002/lary.30240 1482. Lund VJ, Chisholm EJ, Howard DJ, Wei WI. Sinonasal malig nant melanoma: an analysis of 115 cases assessing outcomes of surgery, postoperative radiotherapy and endoscopic resection. Rhinology . 2012;50(2):203-210. https://doi.org/10.4193/Rhino. 11.267 1483. Low CM, Price DL, Moore EJ, et al. Nodal and distant metas tases in sinonasal mucosal melanoma: a population-based analysis. Laryngoscope . 2020;130(3):622-627. https://doi.org/ 10.1002/lary.28065 1484. Balch CM, Gershenwald JE, Soong SJ, et al. Final ver sion of 2009 AJCC melanoma staging and classification. J Clin Oncol . 2009;27(36):6199-6206. https://doi.org/10.1200/ JCO.2009.23.4799 1485. Amit M, Tam S, Abdelmeguid AS, et al. Patterns of treat ment failure in patients with sinonasal mucosal melanoma. Ann Surg Oncol . 2018;25(6):1723-1729. https://doi.org/10.1245/ s10434-018-6465-y 1486. De Virgilio A, Costantino A, Canzano F, et al. Regional disease control in sinonasal mucosal melanoma: systematic review and meta-analysis. HeadNeck . 2021;43(2):705-715. https://doi. org/10.1002/hed.26537 1487. Houette A, Gilain L, Mulliez A, Mom T, Saroul N. Prognos tic value of two tumour staging classifications in patients with sinonasal mucosal melanoma. Eur Ann Otorhinolaryn gol Head Neck Dis . 2016;133(5):313-317. https://doi.org/10.1016/ j.anorl.2016.05.008

1461. Lin N, Qi M, Wang Z, et al. Small cell neuroendocrine car cinoma of paranasal sinuses: radiologic features in 14 cases. J Comput Assist Tomogr . 2021;45(1):135-141. https://doi.org/10. 1097/RCT.0000000000001065 1462. Zhu Q, Zhu W, Wu J, Zhang H. The CT and MRI observations of small cell neuroendocrine carcinoma in paranasal sinuses. World J Surg Oncol . 2015;13:54. https://doi.org/10.1186/s12957 015-0475-z 1463. van der Laan TP, Bij HP, van Hemel BM, et al. The impor tance of multimodality therapy in the treatment of sinonasal neuroendocrine carcinoma. Eur Arch Otorhinolaryngol . 2013;270(9):2565-2568. https://doi.org/10.1007/s00405-013 2554-5 1464. Wang CP, Hsieh CY, Chang YL, et al. Postirradiated neuroendocrine carcinoma of the sinonasal tract. Laryn goscope . 2008;118(5):804-809. https://doi.org/10.1097/MLG. 0b013e3181671491 1465. Alos L, Hakim S, Larque AB, et al. p16 overexpression in high-grade neuroendocrine carcinomas of the head and neck: potential diagnostic pitfall with HPV-related carcino mas. Virchows Arch . 2016;469(3):277-284. https://doi.org/10. 1007/s00428-016-1982-1 1466. Ohmoto A, Sato Y, Asaka R, et al. Clinicopathological and genomic features in patients with head and neck neuroen docrine carcinoma. ModPathol . 2021;34(11):1979-1989. https:// doi.org/10.1038/s41379-021-00869-9 1467. Lopez-Hernandez A, Vivanco B, Franchi A, et al. Genetic profiling of poorly differentiated sinonasal tumours. Science . 2018;8(1):3998. https://doi.org/10.1038/s41598-018-21690-6 1468. Likhacheva A, Rosenthal DI, Hanna E, Kupferman M, Demonte F, El-Naggar AK. Sinonasal neuroendocrine car cinoma: impact of differentiation status on response and outcome. Head Neck Oncol . 2011;3:32. https://doi.org/10.1186/ 1758-3284-3-32 1469. Rosenthal DI, Barker JL, El-Naggar AK, et al. Sinonasal malignancies with neuroendocrine differentiation: pat terns of failure according to histologic phenotype. Cancer . 2004;101(11):2567-2573. https://doi.org/10.1002/cncr.20693 1470. Babin E, Rouleau V, Vedrine PO, et al. Small cell neuroen docrine carcinoma of the nasal cavity and paranasal sinuses. J Laryngol Otol . 2006;120(4):289-297. https://doi.org/10.1017/ S0022215106000594 1471. Hosokawa S, Takahashi G, Baba S, Mineta H. Small cell neu roendocrine carcinomas arising in the head and neck region. J Oral Maxillofac Surg . 2016;74(5):1091-1095. https://doi.org/10. 1016/j.joms.2015.11.015 1472. Sorbye H, Welin S, Langer SW, et al. Predictive and prog nostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study. AnnOncol . 2013;24(1):152-160. https://doi.org/10.1093/annonc/mds276 1473. Patil VM, Joshi A, Noronha V, et al. Neoadjuvant chemother apy in locally advanced and borderline resectable non squamous sinonasal tumors (esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation). Int J Surg Oncol . 2016;2016:6923730. https://doi.org/10.1155/2016/ 6923730 1474. Keilin CA, VanKoevering KK, McHugh JB, McKean EL. Sinonasal neuroendocrine carcinoma: 15 years of experi